TY - JOUR
T1 - Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa
T2 - a systematic review and meta-analysis
AU - Dillon, David G
AU - Gurdasani, Deepti
AU - Riha, Johanna
AU - Ekoru, Kenneth
AU - Asiki, Gershim
AU - Mayanja, Billy N
AU - Levitt, Naomi S
AU - Crowther, Nigel J
AU - Nyirenda, Moffat
AU - Njelekela, Marina
AU - Ramaiya, Kaushik
AU - Nyan, Ousman
AU - Adewole, Olanisun O
AU - Anastos, Kathryn
AU - Azzoni, Livio
AU - Boom, W Henry
AU - Compostella, Caterina
AU - Dave, Joel A
AU - Dawood, Halima
AU - Erikstrup, Christian
AU - Fourie, Carla M
AU - Friis, Henrik
AU - Kruger, Annamarie
AU - Idoko, John A
AU - Longenecker, Chris T
AU - Mbondi, Suzanne
AU - Mukaya, Japheth E
AU - Mutimura, Eugene
AU - Ndhlovu, Chiratidzo E
AU - Praygod, George
AU - Pefura Yone, Eric W
AU - Pujades-Rodriguez, Mar
AU - Range, Nyagosya
AU - Sani, Mahmoud U
AU - Schutte, Aletta E
AU - Sliwa, Karen
AU - Tien, Phyllis C
AU - Vorster, Este H
AU - Walsh, Corinna
AU - Zinyama, Rutendo
AU - Mashili, Fredirick
AU - Sobngwi, Eugene
AU - Adebamowo, Clement
AU - Kamali, Anatoli
AU - Seeley, Janet
AU - Young, Elizabeth H
AU - Smeeth, Liam
AU - Motala, Ayesha A
AU - Kaleebu, Pontiano
AU - Sandhu, Manjinder S
AU - African Partnership for Chronic Disease Research (APCDR)
N1 - CURIS 2013 NEXS 332
PY - 2013/12
Y1 - 2013/12
N2 - Background: Sub-Saharan Africa (SSA) has the highest burden of HIV in the world and a rising prevalence of cardiometabolic disease; however, the interrelationship between HIV, antiretroviral therapy (ART) and cardiometabolic traits is not well described in SSA populations.Methods: We conducted a systematic review and meta-analysis through MEDLINE and EMBASE (up to January 2012), as well as direct author contact. Eligible studies provided summary or individual-level data on one or more of the following traits in HIV+ and HIV-, or ART+ and ART- subgroups in SSA: body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides (TGs) and fasting blood glucose (FBG) or glycated hemoglobin (HbA1c). Information was synthesized under a random-effects model and the primary outcomes were the standardized mean differences (SMD) of the specified traits between subgroups of participants.Results: Data were obtained from 49 published and 3 unpublished studies which reported on 29 755 individuals. HIV infection was associated with higher TGs [SMD, 0.26; 95% confidence interval (CI), 0.08 to 0.44] and lower HDL (SMD, -0.59; 95% CI, -0.86 to -0.31), BMI (SMD, -0.32; 95% CI, -0.45 to -0.18), SBP (SMD, -0.40; 95% CI, -0.55 to -0.25) and DBP (SMD, -0.34; 95% CI, -0.51 to -0.17). Among HIV+ individuals, ART use was associated with higher LDL (SMD, 0.43; 95% CI, 0.14 to 0.72) and HDL (SMD, 0.39; 95% CI, 0.11 to 0.66), and lower HbA1c (SMD, -0.34; 95% CI, -0.62 to -0.06). Fully adjusted estimates from analyses of individual participant data were consistent with meta-analysis of summary estimates for most traits.Conclusions: Broadly consistent with results from populations of European descent, these results suggest differences in cardiometabolic traits between HIV-infected and uninfected individuals in SSA, which might be modified by ART use. In a region with the highest burden of HIV, it will be important to clarify these findings to reliably assess the need for monitoring and managing cardiometabolic risk in HIV-infected populations in SSA.
AB - Background: Sub-Saharan Africa (SSA) has the highest burden of HIV in the world and a rising prevalence of cardiometabolic disease; however, the interrelationship between HIV, antiretroviral therapy (ART) and cardiometabolic traits is not well described in SSA populations.Methods: We conducted a systematic review and meta-analysis through MEDLINE and EMBASE (up to January 2012), as well as direct author contact. Eligible studies provided summary or individual-level data on one or more of the following traits in HIV+ and HIV-, or ART+ and ART- subgroups in SSA: body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides (TGs) and fasting blood glucose (FBG) or glycated hemoglobin (HbA1c). Information was synthesized under a random-effects model and the primary outcomes were the standardized mean differences (SMD) of the specified traits between subgroups of participants.Results: Data were obtained from 49 published and 3 unpublished studies which reported on 29 755 individuals. HIV infection was associated with higher TGs [SMD, 0.26; 95% confidence interval (CI), 0.08 to 0.44] and lower HDL (SMD, -0.59; 95% CI, -0.86 to -0.31), BMI (SMD, -0.32; 95% CI, -0.45 to -0.18), SBP (SMD, -0.40; 95% CI, -0.55 to -0.25) and DBP (SMD, -0.34; 95% CI, -0.51 to -0.17). Among HIV+ individuals, ART use was associated with higher LDL (SMD, 0.43; 95% CI, 0.14 to 0.72) and HDL (SMD, 0.39; 95% CI, 0.11 to 0.66), and lower HbA1c (SMD, -0.34; 95% CI, -0.62 to -0.06). Fully adjusted estimates from analyses of individual participant data were consistent with meta-analysis of summary estimates for most traits.Conclusions: Broadly consistent with results from populations of European descent, these results suggest differences in cardiometabolic traits between HIV-infected and uninfected individuals in SSA, which might be modified by ART use. In a region with the highest burden of HIV, it will be important to clarify these findings to reliably assess the need for monitoring and managing cardiometabolic risk in HIV-infected populations in SSA.
U2 - 10.1093/ije/dyt198
DO - 10.1093/ije/dyt198
M3 - Journal article
C2 - 24415610
SN - 0300-5771
VL - 42
SP - 1754
EP - 1771
JO - International Journal of Epidemiology
JF - International Journal of Epidemiology
IS - 6
ER -